The New York Times article “The Selling of Attention Deficit Disorder” published December 15, 2013 had quoted me towards the end of article. As I had previously written in my blog posting, the quote was taken out of context and deliberately misrepresented my professional article with Medscape. I did send a ... Read More
Tag: Adult Attention Deficit Hyperactivity Disorder
17
Dec2013
The Washington Post took the initiative to write an article in today’s (December 17) paper on ADHD in adults ages sixty and older. This article is also accompanied by a sidebar article discussing adult ADHD Older adults with ADHD are a group that has not been specifically researched and about whom very little is written. The Washington Post article ... Read More
December 17, 2013David W. Goodman, MD
15
Dec2013
Today the New York Times published an article “The Selling of Attention Deficit Disorder” by Alan Schwarz. This is a lengthy article highlighting the increased identification of people with ADHD and the concomitant increase in the prescriptions of effective medications. The article is a feature story on the New York Times ... Read More
December 15, 2013David W. Goodman, MD
18
Oct2013
I am very honored to be an invited faculty speaker at the annual Neuroscience Education Institute Psychopharmacology Congress in Colorado in November 2013. This is a large gathering of psychiatrists, primary care physicians, nurse practitioners, psychologists, clinical social workers, and others who are interested in upgrading their understanding of the use of ... Read More
October 18, 2013David W. Goodman, MD
26
Sep2013
In the September issue 2013 of Attention Magazine, published by the national organization CHADD (Children and Adults with ADHD), my article was published on ADHD in people age 50 and older. There is remarkably little research looking at this population of patients. Clinical medication trials that seek the FDA approval for the ... Read More
September 26, 2013David W. Goodman, MD
13
Sep2013
All ADHD medications that are FDA approved to treat adults have designated maximum daily doses. It is important to understand how these daily maximum doses are determined in order to consider higher doses beyond these thresholds. The FDA receives the clinical registration trial research and it makes a determination of ... Read More
September 13, 2013David W. Goodman, MD
28
Aug2013
Style magazine in Baltimore has published an article in September 2012 edition on stimulant misuse in high school students in Baltimore. The article distinguishes between the use of stimulants for performance enhancement by students vs the use of stimulants to treat legitimately diagnosed ADHD in young adults. I, along with Dr. ... Read More
August 28, 2013David W. Goodman, MD
03
Aug2013
American Professional Society for ADHD and Related Disorders (APSARD) is an organization founded by a national and international group of experts in ADHD treatment and research. The annual meeting, “ADHD Advances: Challenges and Opportunities” being held September 27 – 28, 2013 at the Hyatt Regency Washington on Capitol Hill in ... Read More
August 3, 2013David W. Goodman, MD
12
May2013
psychiatrists at the University Hospital, Auckland, New Zealand for the purpose of exchanging perspectives on diagnosis and treatment of ADHD across the life span. Many of the physicians had been to U.S. conferences that covered this topic so they were familiar with U.S. perspective.
Although we all agree on the validity ... Read More
May 12, 2013David W. Goodman, MD
12
May2013
Because my patients travel from the U.S. or come to consult me from other countries, the question of locating experts in ADHD, especially for adults, comes up often. Here is my suggestion to locate such an expert.
Go to www.pubmed.com. This is the National Institute of Health website on medical publications.
In the ... Read More
May 12, 2013David W. Goodman, MD